If you are ready to take your drug development program to the next level, we encourage you to join us in Boston for the upcoming TACT meeting. Seize this opportunity to engage with top-tier experts, refine your strategy, and propel your therapeutic innovation forward.
News
Unlocking the Future of Rare Diseases: TREAT-NMD at World Orphan Drug Congress USA 2024
TREAT-NMD is honoured to be a media partner for this years World Orphan Drug Congress USA 2024 being held at the Boston Convention & Exhibition Centre from April 23 to April 25, 2024.
Applications for the TREAT-NMD Masterclass Event 2024 are now OPEN!
We are now accepting applications for our Masterclass Event 2024 in Dubai, UAE. This event is primarily for healthcare professionals, clinical researchers and allied health providers working in the Middle East region.
TREAT-NMD Unveils Groundbreaking Programme to Revolutionise Rare Disease Treatment
TREAT-NMD are proud to announce the launch of the PaLaDIn project, an incredibly exciting and ambitious new project that aims to accelerate research, understanding and treatment for neuromuscular and other rare diseases.
TREAT-NMD Joins the 21st International Conference on Duchenne and Becker Muscular Dystrophy in Rome
TREAT-NMD will be attending the Parent Project aps 21st International Conference on Duchenne and Becker Muscular Dystrophy in Rome. CEO, David Allison, and Neil Bennett, Head of Real World Evidence will be discussing the PaLaDIn project, and ‘The Interactium’ an innovative platform for data collection.
CureDuchenne Announces Educational Events for Families and Caregivers of Individuals with Duchenne or Becker Muscular Dystrophy
CureDuchenne has announced its schedule of CureDuchenne Cares workshops and dinner sessions for the first half of 2024, as well as its annual conference.
